Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Hypofractionated Radiation Therapy in Patients With Breast Cancer [Phase 3]
Phase 3 trial evaluating hypofractionated radiation therapy in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation [Phase 2]
Phase 2 trial updating the combination of fulvestrant and anlotinib in HR+/HER2- metastatic breast cancer with FGFR mutation.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer [Phase 1, Phase 2]
A phase 1/2 study of GDC-0810 as a single agent or in combination with palbociclib and/or an LHRH agonist in women with locally advanced or …
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer [Phase 1, Phase 2]
Clinical trial update evaluating safety and efficacy of estetrol in postmenopausal women with advanced estrogen receptor-positive breast can…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy? [NA]
Completed clinical trial evaluating HER2-targeted PET/CT imaging to identify unsuspected HER2-positive breast cancer metastases that may be …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC [Phase 3]
Phase 3 trial comparing ribociclib-endocrine therapy versus chemotherapy as first-line treatment in visceral metastatic breast cancer was te…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer [Phase 4]
Phase 4 trial comparing the immunogenicity of Peg-filgrastim versus Neulasta as an adjunct to chemotherapy in breast cancer; results have be…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer [Phase 1]
Phase 1 study evaluating DS-8201a (trastuzumab deruxtecan) effect on QT/QTc interval and pharmacokinetics in HER2-expressing breast cancer h…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery [Phase 2]
Phase 2 trial update for AVB-620 in women with primary breast cancer undergoing surgery has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer [Phase 2]
Phase 2 trial evaluating the efficacy of anastrozole and fulvestrant in ER-positive, HER2-negative operable breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature [Phase 2]
A Phase 2 trial evaluating the efficacy of rucaparib in metastatic breast cancer with a BRCAness genomic signature has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Pilot Clinical Study on a Low-power Electromagnetic Wave Breast Imaging Device for Cancer Screening Purposes. [NA]
Pilot study of a low-power electromagnetic wave breast imaging device for cancer screening has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer [Phase 2]
Phase 2 trial update on pyrotinib as a neoadjuvant treatment for HER2-positive early breast cancer with non-objective response.
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating SHR6390 in combination with Fulvestrant for HR-positive, HER2-negative advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with reparixin vs placebo in metastatic triple-negative breast cancer; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating SHR6390 with letrozole or anastrozole in HR-positive, HER2-negative advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer [Phase 2]
Phase 2 trial update evaluating concomitant and sequential radiohormonotherapy in adjuvant breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN) [Phase 2]
Phase 2 trial comparing tyrosine kinase inhibitors versus pertuzumab in HER2-positive breast cancer with active brain metastases is ongoing …
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: The BEACON Study (Breast Cancer Outcomes With NKTR-102) [Phase 3]
Phase 3 BEACON study completed for NKTR-102 in locally recurrent and metastatic breast cancer; results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: The PIONEER-01 Study of the Imagio Breast Imaging System [NA]
Clinical trial update for the PIONEER-01 study of the Imagio Breast Imaging System has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer [Phase 2]
Phase 2 rollover study of weekly paclitaxel (BMS-181339) in advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing pyrotinib to pertuzumab, in combination with neoadjuvant trastuzumab and nab-paclitaxel, for HER2-positive early or …
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: S 81694 Plus Paclitaxel in Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for S 81694 combined with Paclitaxel in metastatic breast cancer and metastatic triple-negative breast cancer, complet…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer [Phase 4]
Phase 4 trial evaluating rheumatologic effects of anastrozole and letrozole as adjuvant therapy in post-menopausal women with breast cancer;…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer [Phase 3]
Phase 3 trial evaluating pyrotinib after adjuvant trastuzumab in women with early-stage breast cancer is ongoing; no results yet reported.